Cuorips Inc. (4894.T)

JPY 8340.0

(12.7%)

Gross Profit Summary of Cuorips Inc.

  • Cuorips Inc.'s latest annual gross profit in 2023 was 9.63 Million JPY , down -54.16% from previous year.
  • Cuorips Inc.'s latest quarterly gross profit in 2024 Q1 was -17.62 Million JPY , down -458.58% from previous quarter.
  • Cuorips Inc. reported a annual gross profit of 21.01 Million JPY in annual gross profit 2022, up 97.24% from previous year.
  • Cuorips Inc. reported a annual gross profit of 10.65 Million JPY in annual gross profit 2021, up 7619.57% from previous year.
  • Cuorips Inc. reported a quarterly gross profit of 9.63 Million JPY for 2023 FY, down -54.16% from previous quarter.
  • Cuorips Inc. reported a quarterly gross profit of 4.91 Million JPY for 2023 Q4, up 860.16% from previous quarter.

Annual Gross Profit Chart of Cuorips Inc. (2023 - 2020)

Historical Annual Gross Profit of Cuorips Inc. (2023 - 2020)

Year Gross Profit Gross Profit Growth
2023 9.63 Million JPY -54.16%
2022 21.01 Million JPY 97.24%
2021 10.65 Million JPY 7619.57%
2020 138 Thousand JPY 0.0%

Peer Gross Profit Comparison of Cuorips Inc.

Name Gross Profit Gross Profit Difference
KOHJIN BIO CO LTD 1.88 Billion JPY 99.488%
PRISM BioLab Co.,LTD 80.3 Million JPY 88.007%
GNI Group Ltd. 22.43 Billion JPY 99.957%
Linical Co., Ltd. 3.77 Billion JPY 99.745%
Trans Genic Inc. 2.24 Billion JPY 99.572%
MEDINET Co., Ltd. 98.25 Million JPY 90.198%
Soiken Holdings Inc. 2.48 Billion JPY 99.612%
Cytori Cell Research Institute, Inc. 1.29 Billion JPY 99.255%
AnGes, Inc. -3.06 Billion JPY 100.314%
OncoTherapy Science, Inc. -177.71 Million JPY 105.419%
Nxera Pharma Co., Ltd. 9.66 Billion JPY 99.9%
Immuno-Biological Laboratories Co., Ltd. 517.29 Million JPY 98.138%
NanoCarrier Co., Ltd. 110.95 Million JPY 91.32%
Carna Biosciences, Inc. 1.45 Billion JPY 99.336%
CanBas Co., Ltd. -984 Million JPY 100.979%
D. Western Therapeutics Institute, Inc. 391.69 Million JPY 97.541%
RaQualia Pharma Inc. 1.65 Billion JPY 99.418%
Chiome Bioscience Inc. 398.59 Million JPY 97.584%
Kidswell Bio Corporation 1.03 Billion JPY 99.073%
PeptiDream Inc. 17.21 Billion JPY 99.944%
Oncolys BioPharma Inc. 30.6 Million JPY 68.531%
Ribomic Inc. -10.5 Million JPY 191.706%
SanBio Company Limited -14.5 Million JPY 166.402%
Healios K.K. 108 Million JPY 91.082%
BrightPath Biotherapeutics Co., Ltd. -341 Thousand JPY 2924.34%
Kubota Pharmaceutical Holdings Co., Ltd. -59.04 Million JPY 116.311%
Delta-Fly Pharma, Inc. -1.51 Million JPY 736.971%
StemRIM -44.34 Million JPY 121.716%
CellSource Co., Ltd. 3.18 Billion JPY 99.698%
FunPep Company Limited -680.28 Million JPY 101.416%
Kringle Pharma, Inc. 69.25 Million JPY 86.092%
Stella Pharma Corporation 217.29 Million JPY 95.568%
TMS Co., Ltd. -6.95 Million JPY 238.576%
Noile-Immune Biotech Inc. 314.56 Million JPY 96.938%
K Pharma,Inc. 910 Million JPY 98.942%
Takara Bio Inc. 25.45 Billion JPY 99.962%
ReproCELL Incorporated 1.1 Billion JPY 99.128%
PhoenixBio Co., Ltd. 1.19 Billion JPY 99.194%
StemCell Institute Inc. 1.57 Billion JPY 99.389%
Japan Tissue Engineering Co., Ltd. 1.66 Billion JPY 99.422%
CellSeed Inc. 107.15 Million JPY 91.012%